3SBio (HKSE:01530) Total Equity : HK$18,168 Mil (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is 3SBio Total Equity?

3SBio's total equity for the quarter that ended in Jun. 2024 was HK$18,168 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

3SBio Total Equity Historical Data

The historical data trend for 3SBio's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Total Equity Chart

3SBio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Equity

Get a 7-Day Free Trial

15,521.27

17,947.99

17,156.74

18,062.23

19,256.89

3SBio Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Equity	Get a 7-Day Free Trial															17,156.74	17,461.58	18,062.23	18,167.61	19,256.89

3SBio Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

3SBio's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity	=	Total Assets(Q: Dec. 2023 )	-	Total Liabilities(Q: Dec. 2023 )
	=	25840.557	-	7778.33
	=	18,062

3SBio's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	25779.095	-	7611.486
	=	18,168

3SBio Total Equity Related Terms

Thank you for viewing the detailed overview of 3SBio's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (HKSE:01530) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Lou Jing	2305 Beneficiary of a trust
Jpmorgan Chase & Co.	2502 Approved lending agent
Hsbc Holdings Plc	2302 Custodian
Citic Securities Company Limited	2201 Interest of corporation controlled by you
Citron Pe Associates, L.p.	2201 Interest of corporation controlled by you
Citron Pe Funds Limited	2201 Interest of corporation controlled by you
Citron Pe Holdings Limited	2201 Interest of corporation controlled by you
Cpechina Fund, L.p.	2201 Interest of corporation controlled by you
Cs Sunshine Investment Limited	2101 Beneficial owner
Xing Lily
Century Sunshine Limited
Decade Sunshine Limited
Lambda International Limited

3SBio Headlines

No Headlines